跳轉至內容
Merck
全部照片(1)

文件

SML1100

Sigma-Aldrich

Varespladib

≥98% (HPLC)

同義詞:

2-[[3-(2-氨基-2-氧代乙酰基)-2-乙基-1-(苯甲基)-1H-吲哚-4-基]氧基]-乙酸, A-001, LY-315920, LY315920

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C21H20N2O5
CAS號碼:
分子量::
380.39
分類程式碼代碼:
41106300
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 10 mg/mL, clear

儲存溫度

−20°C

InChI

1S/C21H20N2O5.Na/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13;/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25);/q;+1/p-1

InChI 密鑰

XZZUHXILQXLTGV-UHFFFAOYSA-M

應用

伐瑞拉迪作为分泌型磷脂酶A2(sPLA2)抑制剂的应用实例:
  • 检测其对神经鞘氨醇半乳糖苷(psychosine)诱导的人星形胶质细胞毒性的作用
  • 检测其对黑蛇(P. colletti)蛇毒的中和作用
  • 检测其联用蛇毒金属蛋白酶(SVMP)抑制剂Marimastat,对抗蝰蛇毒伤的保护作用

生化/生理作用

伐瑞拉迪(Varespladib)是抗蝰蛇和眼镜蛇毒液的有效解毒药,主要用于蛇咬伤治疗。根据体外结构研究,它可作用于磷脂酶A2(PLA2)样毒素的疏水性通道。它可阻断sPLA2相关的炎症级联反应。
伐瑞拉迪是一种有效且选择性的分泌型磷脂酶 A2(sPLA2)抑制剂。 化合物伐瑞拉迪在低 nM 浓度下抑制人和小鼠 sPLA2 IIA、V 和 X 组酶。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Christina N Zdenek et al.
Toxicology letters, 330, 176-184 (2020-05-23)
Venoms from Pseudechis species (Australian black snakes) within the Elapidae family are rich in anticoagulant PLA2 toxins, with the exception of one species (P. porphyriacus) that possesses procoagulant mutated forms of the clotting enzyme Factor Xa. Previously the mechanism of
Laura-Oana Albulescu et al.
Nature communications, 11(1), 6094-6094 (2020-12-17)
Snakebite is a medical emergency causing high mortality and morbidity in rural tropical communities that typically experience delayed access to unaffordable therapeutics. Viperid snakes are responsible for the majority of envenomings, but extensive interspecific variation in venom composition dictates that
Guilherme H M Salvador et al.
Scientific reports, 9(1), 17203-17203 (2019-11-22)
The World Health Organization recently listed snakebite envenoming as a Neglected Tropical Disease, proposing strategies to significantly reduce the global burden of this complex pathology by 2030. In this context, effective adjuvant treatments to complement conventional antivenom therapy based on
Cedric Misslin et al.
PloS one, 12(11), e0187217-e0187217 (2017-11-03)
Krabbe disease is a fatal rare inherited lipid storage disorder affecting 1:100,000 births. This illness is caused by mutations in the galc gene encoding for the enzyme galactosylceramidase (GALC). Dysfunction of GALC has been linked to the toxic build-up of

文章

Discover Bioactive Small Molecules for Lipid Signaling Research

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務